Intensive Serum Urate Lowering With Oral Urate‐Lowering Therapy for Erosive Gout: A Randomized Double‐Blind Controlled Trial

Overview of attention for article published in Arthritis & Rheumatology, April 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 2 news outlets
twitter: 18 X users

facebook: 2 Facebook pages
bluesky: 1 Bluesky user

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 4 news stories from 2 outlets.

First-Line ULT for Gout: Is a Mechanism-Based Approach Best?

Medscape, 17 Dec 2024

For gout, xanthine oxidase (XO) inhibitors are the choice for first-line urate-lowering therapy (ULT) according to the 2020…

Gout Experts Approve New Remission Criteria for the Crystal-Associated Arthritis

Medscape, 25 Nov 2024

In a nearly unanimous vote at the annual research symposium of the Gout Hyperuricemia and Crystal-Associated Disease Network (G-C…

Super-low uric acid may not be best for erosive gout

Pediatric News , 11 Jan 2022

Lowering the serum urate target to less than 0.20 mmol/L (

Super-Low Uric Acid May Not Be Best for Erosive Gout

Medscape, 11 Jan 2022

Lowering the serum urate target to less than 0.20 mmol/L (

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.